# NIH Reporter #5P30CA014520-52

Drug Development Core

**Recipient:** University of Wisconsin–Madison

**Award Amount:** $102,910.00
**Ceiling:** $102,910.00

**Awarded:** September 17, 2026

**Identifier:** 5P30CA014520-52

The National Cancer Institute awarded funding to the University of Wisconsin–Madison for its Drug Development Core. The core provides drug-discovery and optimization services, supports clinical-trial drug analysis, and trains researchers and staff.

### Description

Funding for the Drug Development Core, which supports UWCCC research and clinical trials through drug screening, medicinal chemistry, lead optimization, pharmacokinetic and pharmacodynamic services, and training.

[View original record](https://reporter.nih.gov/search/J7l2tQ4hHkqRePwGq3m5kA/project-details/11408608)